Skip to main content

Biodesix To Use Sapio's LIMS

NEW YORK (GenomeWeb News) - Sapio Sciences said today that molecular diagnostics developer Biodesix has purchased its Exemplar laboratory information management system.

Biodesix is developing mass spectrometry-based molecular diagnostics to help physicians diagnose, treat, and monitor disease.

Sapio said that the company was looking for a LIMS that could track samples, support biobanking, and integrate with its mass spectrometry instruments.

Financial terms of the agreement were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.